
    
      Hypercholesterolemic patients with documented CAD, on chronic fortnightly LDL-apheresis
      treatment will be enrolled in this study.

      Blood samples will be collected before and after a single LDL-Apheresis treatment to asses
      PTX3, HsCRP, IL6, IL10, Fibrinogen and lipid plasma levels.
    
  